Skip to main content
All lobbying filings

ADVANCED MEDICAL TECHNOLOGY ASSN

Lobbying for ADVANCED MEDICAL TECHNOLOGY ASSN

 Filing · LD-2 quarterly report Q3 report
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 20, 2026
Expenses
$1,080,000
What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
District of Columbia

Official filing document

 Lobbying activity 6

Issues related to coverage of telehealth services Issues related to Medicare coverage for digital health technologies - S. 1399/H.R. 6197 Issues related to S. 1717/H.R. 5343 Ensuring Patient Access to Critical Breakthrough Products Act Issues related to S. 2761/H.R. 5269 Lab Payments and Results Act Issues related to Medicare coverage of FDA's breakthrough devices Issues related to coverage of diabetes devices and supplies Issues related to Home Health Rule

Issues related to Privacy Legislation Issues related to remanufacturing and servicing medical devices Issues related to the medical supply chain Issues related to the competitiveness of the medtech industry and the impact of Federal Policies Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to coverage and reimbursement of diagnostic tests Issues related to the use of Artificial Intelligence Issues related to MDUFA Reauthorization Issues related to PFAS Chemical regulation HR 1539 - the Medical Device Electronic Labeling Act Issues related to National Defense Authorization Act Issues related to FDA regulation of diagnostic tests Issues related to the Countering CCP Act (S. 4939) Issues related to the Health Care Cybersecurity and Resiliency Act of 2025 (S. 3315)

Issues related to appropriations and user fee funding for the Food and Drug Administration

Issues related to small business taxes

Tariffs on medical devices United States-Mexico-Canada Agreement (USMCA) Global Trade and EU Tariffs

Issues related to the reauthorization of the Small Business Innovation Research (SBIR) program. Issues related to small business taxes.

 Bills named in this filing 9
  • S. 1399
    Health Tech Investment Act
  • H.R. 6197
    Health Tech Investment Act
  • S. 1717
    Ensuring Patient Access to Critical Breakthrough Products Act of 2025
  • H.R. 5343
    Ensuring Patient Access to Critical Breakthrough Products Act
  • S. 2761
    RESULTS Act
  • H.R. 5269
    RESULTS Act
  • H.R. 1539
    Medical Device Electronic Labeling Act
  • S. 4939
    Countering CCP Act
  • S. 3315
    Health Care Cybersecurity and Resiliency Act of 2026

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem